Literature DB >> 6117634

Amine oxidase in human blood vessels and non-vascular smooth muscle.

R Lewinsohn.   

Abstract

The pattern of amine oxidation was studied in human blood vessels at various stages of development, and in tissues with muscular layers made up predominantly or exclusively of smooth muscle. Specific activity of benzylamine oxidase, present in all vascular tissues examined, was higher in vessels than in other tissue; the enzyme, in organs rich in non-vascular smooth muscle, though lower than in blood vessels, was significantly higher than in striated muscle or connective tissue. The localization of benzylamine oxidase activity in smooth muscle, as opposed to connective tissue, may have important physiological implications.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6117634     DOI: 10.1111/j.2042-7158.1981.tb13868.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  10 in total

1.  The influence of amine metabolizing enzymes on the pharmacology of tyramine in the isolated perfused mesenteric arterial bed of the rat.

Authors:  J Elliott; B A Callingham; D F Sharman
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

2.  Purification and characterization of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) from bovine lung.

Authors:  J M Lizcano; K F Tipton; M Unzeta
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

3.  Inhibitory effect of drugs used in the treatment of Parkinson's disease on plasma monoamine oxidase activity.

Authors:  H Coelho; M Azevedo; C Manso
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

4.  The role of semicarbazide-sensitive amine oxidase with a high affinity for benzylamine (Bz. SSAO) in the catabolism of histamine in the mesenteric arterial bed of the rat.

Authors:  F Buffoni; G Banchelli; G Ignesti; R Pirisino; L Raimondi
Journal:  Agents Actions       Date:  1994-08

5.  Plasma amine oxidase activities in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase.

Authors:  D L Murphy; K B Sims; F Karoum; N A Garrick; A de la Chapelle; E M Sankila; R Norio; X O Breakefield
Journal:  J Neural Transm Gen Sect       Date:  1991

6.  Substrates of semicarbazide-sensitive amine oxidase co-operate with vanadate to stimulate tyrosine phosphorylation of insulin-receptor-substrate proteins, phosphoinositide 3-kinase activity and GLUT4 translocation in adipose cells.

Authors:  G Enrique-Tarancón; I Castan; N Morin; L Marti; A Abella; M Camps; R Casamitjana; M Palacín; X Testar; E Degerman; C Carpéné; A Zorzano
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

Review 7.  Semicarbazide-sensitive amine oxidase (SSAO) in the brain.

Authors:  Toshio Obata
Journal:  Neurochem Res       Date:  2002-04       Impact factor: 3.996

8.  Stimulation of glucose transport by semicarbazide-sensitive amine oxidase activity in adipocytes from diabetic rats.

Authors:  A Abella; L Marti; C Carpéné; M Palacín; X Testar; A Zorzano
Journal:  J Physiol Biochem       Date:  2003-09       Impact factor: 4.158

9.  The interaction of hydralazine with a semicarbazide-sensitive amine oxidase in brown adipose tissue of the rat. Its use as a radioactive ligand for the enzyme.

Authors:  M A Barrand; B A Callingham
Journal:  Biochem J       Date:  1985-12-01       Impact factor: 3.857

10.  Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes.

Authors:  Hung-Yuan Li; Hung-An Lin; Feng-Jung Nien; Vin-Cent Wu; Yi-Der Jiang; Tien-Jyun Chang; Hsien-Li Kao; Mao-Shin Lin; Jung-Nan Wei; Cheng-Hsin Lin; Shyang-Rong Shih; Chi-Sheng Hung; Lee-Ming Chuang
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.